Cyclophosphamide trials for Osteosarcoma

All Cyclophosphamide trials · All Osteosarcoma trials

Phase breakdown

Recruiting trials studying Cyclophosphamide for Osteosarcoma

• B7-H3-Specific Chimeric Antigen Receptor Autologous T-Cell Therapy for Pediatric Patients With Solid Tumors (3CAR)
  NCT04897321 · Phase: Phase 1 · Ages: Up to 21 Years · Sex: All (male and female) · 1 location
• START: Safety and Anti-Tumor Activity of PeptiCRAd-1 in Treatment of Cancer
  NCT05492682 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · 7 locations
• Study of CRX100 as Monotherapy and in Combination With Pembrolizumab in Patients With Advanced Solid Malignancies
  NCT04282044 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · 6 locations

Common questions

How many trials study Cyclophosphamide for Osteosarcoma?

3 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.